tiprankstipranks
Argent Biopharma (RGTLF)
OTHER OTC:RGTLF
US Market

Argent Biopharma (RGTLF) Financial Statements

Compare
30 Followers

Argent Biopharma Financial Overview

Argent Biopharma's market cap is currently $7.35M. The company's EPS TTM is $-0.351; its P/E ratio is ―; Argent Biopharma is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue
Gross Profit$ 203.70K$ 1.45M$ 1.81M$ 1.31M$ 174.66K
Operating Income$ -18.67M$ -16.88M$ -14.43M$ -12.07M$ -11.80M
EBITDA$ -15.77M$ -11.05M$ -20.90M$ -14.58M$ -18.15M
Net Income$ -17.53M$ -11.76M$ -20.83M$ -15.87M$ -19.36M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 10.79M$ 9.98M$ 18.56M$ 24.24M$ 7.93M
Total Debt$ 1.04M$ 575.14K$ 2.25M$ 6.02M$ 1.90M
Net Debt$ 341.85K$ 335.32K$ 366.26K$ 584.33K$ 25.85K
Total Liabilities$ 16.61M$ 18.02M$ 13.38M$ 10.41M$ 4.83M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -14.80M$ -11.38M$ -13.11M--
Operating Cash Flow$ -14.66M$ -11.99M$ -12.16M--
Investing Cash Flow
Financing Cash Flow
Currency in USD

Argent Biopharma Earnings and Revenue History

Argent Biopharma Debt to Assets

Argent Biopharma Cash Flow

Argent Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis